Site Map
Posts
- Category: Wp Feeds (continued)
- FDA Warns of Fake Avastin
- FDA Warns of Fracture Risk with PPIs
- FDA Warns of Gastric Balloon Deaths
- FDA Warns of Heart Risk with Imodium
- FDA Warns of New Infections With TNF Blockers
- FDA Warns on Proper Dosing for Liver Drug
- FDA, Hospira Warn About Blood Bag Problem
- FDA: Bleeding Risk With Antacid-Aspirin Combo
- FDA: Califf Wins Unanimous Support of Senate Committee
- FDA: Don't Mix New HCV Drug with HIV Drugs
- FDA: HCV Drug Interferes With HIV Meds
- FDA: Unapproved Duodenoscope OK to Use
- Fecal Biotherapy for IBD Holds Promise and Problems
- Fecal Blood Test Cuts Colon Cancer Deaths
- Fecal Transplant Good For the Brain? (CME/CE)
- Fecal Transplant May Be New IBD Tx Option (CME/CE)
- Fecal Transplant, Now in Pill Form (CME/CE)
- Fecal Transplants Area of Focus (CME/CE)
- Fecal Transplants Show Promise in Kids With Recurrent C. Diff (CME/CE)
- Fecal Tx Flunks IBD Test but Optimism High (CME/CE)
- Federal Judge Rules Against ACA Subsidies
- Fertility Help Not Equal for Cancer Patients (CME/CE)
- Fewer Kids Die While Waiting for New Organs (CME/CE)
- Fiber Cuts Crohn's Risk in Women (CME/CE)
- Fibrosis Risk High in Kids With Transplanted Livers (CME/CE)
- Filled to the Brim
- Finding Value-Based Payment Measures That Work
- First Fecal Hb Value May Predict Risk of Cancer (CME/CE)
- First Robotic TAR Procedure: The General Surgery News Report
- Five Healthcare-Related Cases Scalia Left Behind
- Fixed-Dose HCV Combo OK With Ribavirin Substitute (CME/CE)
- Flu Rates Higher in IBD (CME/CE)
- FOBT Not Fooled by Upper GI Bleeds (CME/CE)
- Four-Drug Combo Better to Wipe Out H. Pylori (CME/CE)
- Four-Drug Combo for HCV Shows Early Promise
- Fraud Rounds: Grant Fakery Earns Practice Ban
- Free Colonoscopies Save $$: Gastro and Endo News Report
- Friday Feedback: Biggest Health Policy Stories of 2015
- Friday Feedback: Does 'Cancer Report' Improve Practice?
- Friday Feedback: Getting into the Weeds of Marijuana Policy
- Friday Feedback: Giving Terminally Ill Patients the 'Right-to-Try'
- Friday Feedback: When Drug Price Is a Factor
- Frozen Fecal Matter an Option for C. Diff (CME/CE)
- FSH Receptor Expressed in Tumors (CME/CE)
- FSMB Plan Offers Pathway to Multistate License
- Gadobutrol Deemed Safe in Early Analysis
- Gains in Colorectal Ca Good, But Not Perfect
- Gallbladder Polyp Size Can Guide Treatment (CME/CE)
- Gaps in CRC Screening in Seniors (CME/CE)
- Gary Reedy Readies ACS for Change
